TLR4 and TLR2 activation is differentially associated with age during Parkinson's disease

Immunological Investigations
Hermínio Maurício da Rocha SobrinhoFátima Ribeiro-Dias

Abstract

Parkinson's disease (PD) is an age-related neurodegenerative disease characterized by loss of dopaminergic neurons associated with neuroinflammation. Toll-like receptors (TLRs) are expressed in peripheral blood leukocytes and also in neurons and glial cells mediating inflammation. This study aimed to investigate the peripheral blood leukocyte response to TLR2 and TLR4 agonists in young and elderly PD patients. Two groups of patients with PD were evaluated (≤ 55 years old and ≥ 65 years old), age-matched with healthy controls (n = 26). Severity of PD was evaluated by Unified Parkinson's Disease Rating Scale (UPDRS). Whole blood cultures were stimulated with lipopolysaccharide (LPS), a TLR4 agonist or Pam3Cys (Pam), a TLR2 agonist. Tumor necrosis factor alpha (TNFα) and interleukin 10 (IL-10) were measured by immunoenzimatic assay. 6 h-TNFα production was increased after TLR4 stimulation, mainly in young PD patients, whereas TLR2-induced TNFα and IL-10 levels were decreased in PD patients independent of age (p < 0.05). A reverse correlation between LPS-induced TNFα production and age was observed in PD patients and controls, but TNFα induced by TLR2 agonist was not associated with age of PD patients or controls. TNFα production i...Continue Reading

References

May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jun 1, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·H BesslerM Djaldetti
Jul 23, 1999·Acta Neurologica Scandinavica·R J DobbsD W Peterson
May 2, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Irene LitvanUNKNOWN Movement Disorders Society Scientific Issues Committee
Mar 5, 2004·The Journal of Infectious Diseases·Desiree van der KleijMaria Yazdanbakhsh
Mar 9, 2004·Journal of Clinical Periodontology·S J FokkemaU Van der Velden
Jan 5, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·David van DuinAlbert C Shaw
Jun 12, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Louisa C JohnstonJohn Forsayeth
Aug 6, 2008·Brain, Behavior, and Immunity·M RealeM Onofrj
Aug 8, 2008·Immunopharmacology and Immunotoxicology·Maria Antonietta PanaroGiuseppe Nicolardi
Mar 3, 2009·Neurology·Andrew J Lees
Jan 27, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexander PandaAlbert C Shaw
Sep 15, 2012·Current Biology : CB·Teresa Niccoli, Linda Partridge
Feb 13, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Natalja FunkSaskia Biskup
Jun 25, 2013·Journal of the American Medical Directors Association·Martin MichaudFati Nourhashemi
Nov 28, 2013·Journal of Parkinson's Disease·George T KannarkatMalú G Tansey
Oct 7, 2014·Acta Neuropathologica·Veselin GrozdanovKarin M Danzer
Dec 3, 2014·Neuroscience·N DzamkoG M Halliday
Feb 18, 2016·Neuroimmunomodulation·Delson José da SilvaFátima Ribeiro-Dias
Jul 1, 2016·Experimental Neurobiology·Changyoun KimSeung-Jae Lee
Feb 9, 2017·Molecular Neurobiology·Natalia Pessoa RochaAntonio Lucio Teixeira

❮ Previous
Next ❯

Citations

Oct 16, 2019·Journal of Cellular Physiology·Navid ShomaliSiamak Sandoghchian Shotorbani
Jul 10, 2019·Immunological Investigations
Jan 11, 2021·Sleep Medicine·Arunima RoyZachary A Kaminsky
Jul 15, 2021·Journal of Neuroscience Research·Hermínio Maurício da Rocha SobrinhoFátima Ribeiro-Dias

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.